|
Atomistry » Fluorine » PDB 3nlz-3og7 » 3og7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Fluorine » PDB 3nlz-3og7 » 3og7 » |
Fluorine in PDB 3og7: B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032Enzymatic activity of B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032
All present enzymatic activity of B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032:
2.7.11.1; Protein crystallography data
The structure of B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032, PDB code: 3og7
was solved by
Y.Zhang,
K.Y.Zhang,
C.Zhang,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 3og7:
The structure of B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032 also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032
(pdb code 3og7). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032, PDB code: 3og7: Jump to Fluorine binding site number: 1; 2; Fluorine binding site 1 out of 2 in 3og7Go back to Fluorine Binding Sites List in 3og7
Fluorine binding site 1 out
of 2 in the B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032
Mono view Stereo pair view
Fluorine binding site 2 out of 2 in 3og7Go back to Fluorine Binding Sites List in 3og7
Fluorine binding site 2 out
of 2 in the B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032
Mono view Stereo pair view
Reference:
G.Bollag,
P.Hirth,
J.Tsai,
J.Zhang,
P.N.Ibrahim,
H.Cho,
W.Spevak,
C.Zhang,
Y.Zhang,
G.Habets,
E.A.Burton,
B.Wong,
G.Tsang,
B.L.West,
B.Powell,
R.Shellooe,
A.Marimuthu,
H.Nguyen,
K.Y.Zhang,
D.R.Artis,
J.Schlessinger,
F.Su,
B.Higgins,
R.Iyer,
K.D'andrea,
A.Koehler,
M.Stumm,
P.S.Lin,
R.J.Lee,
J.Grippo,
I.Puzanov,
K.B.Kim,
A.Ribas,
G.A.Mcarthur,
J.A.Sosman,
P.B.Chapman,
K.T.Flaherty,
X.Xu,
K.L.Nathanson,
K.Nolop.
Clinical Efficacy of A Raf Inhibitor Needs Broad Target Blockade in Braf-Mutant Melanoma. Nature V. 467 596 2010.
Page generated: Wed Jul 31 21:12:53 2024
ISSN: ISSN 0028-0836 PubMed: 20823850 DOI: 10.1038/NATURE09454 |
Last articlesZn in 9JYWZn in 9IR4 Zn in 9IR3 Zn in 9GMX Zn in 9GMW Zn in 9JEJ Zn in 9ERF Zn in 9ERE Zn in 9EGV Zn in 9EGW |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |